BCL2, BCL2 apoptosis regulator, 596

N. diseases: 1456; N. variants: 27
Source: ALL
Disease Type Disease Class Semantic Type N. genes d N. SNPs d Score gda EL gda EI gda N. PMIDs N. SNPs gda First Ref. Last Ref.
CUI: C1269955
Disease: Tumor Cell Invasion
Tumor Cell Invasion 		phenotype Neoplastic Process 6626 169 0.100 None 0.966 87 1992 2019
CUI: C4722085
Disease: Malignant neoplasm of colon and/or rectum
Malignant neoplasm of colon and/or rectum 		disease Neoplastic Process 3669 502 0.100 None 0.973 37 1997 2020
CUI: C4285066
Disease: Double-Hit Lymphoma
Double-Hit Lymphoma 		disease Neoplastic Process 24 0.100 None 1.000 34 2012 2020
CUI: C1868683
Disease: B-CELL MALIGNANCY, LOW-GRADE
B-CELL MALIGNANCY, LOW-GRADE 		disease Neoplastic Process 350 19 0.100 None 0.935 31 1 1992 2018
CUI: C0751606
Disease: Adult Acute Lymphocytic Leukemia
Adult Acute Lymphocytic Leukemia 		disease Neoplastic Process 860 154 0.100 None 1.000 26 1996 2019
CUI: C1608408
Disease: Malignant transformation
Malignant transformation 		phenotype Neoplastic Process 1027 20 0.100 None 0.944 18 1995 2018
CUI: C0374997
Disease: Helicobacter pylori (H. pylori) infection in conditions classified elsewhere and of unspecified site
Helicobacter pylori (H. pylori) infection in conditions classified elsewhere and of unspecified site 		disease Disease or Syndrome 593 24 0.100 None 0.900 10 1999 2012
CUI: C1654637
Disease: androgen independent prostate cancer
androgen independent prostate cancer 		disease Neoplastic Process 190 5 0.080 None 1.000 8 1997 2017
CUI: C3642345
Disease: Luminal A Breast Carcinoma
Luminal A Breast Carcinoma 		disease Neoplastic Process 153 11 0.080 None 0.750 8 2007 2019
CUI: C4524186
Disease: Double expressor lymphoma
Double expressor lymphoma 		disease Neoplastic Process 4 0.080 None 0.875 8 2016 2019
CUI: C1332225
Disease: Aggressive Non-Hodgkin Lymphoma
Aggressive Non-Hodgkin Lymphoma 		disease Neoplastic Process 57 1 0.070 None 1.000 7 1996 2020
CUI: C2938924
Disease: Oestrogen receptor positive breast cancer
Oestrogen receptor positive breast cancer 		disease Neoplastic Process 510 58 0.070 None 1.000 7 2007 2019
CUI: C0278488
Disease: Carcinoma breast stage IV
Carcinoma breast stage IV 		disease Neoplastic Process 573 14 0.060 None 0.833 6 2000 2019
CUI: C1739135
Disease: Progression of prostate cancer
Progression of prostate cancer 		disease Neoplastic Process 398 7 0.060 None 1.000 6 1999 2017
CUI: C3854222
Disease: Human immunodeficiency virus (HIV) II infection category B1
Human immunodeficiency virus (HIV) II infection category B1 		disease Disease or Syndrome 985 56 0.060 None 1.000 6 1996 2004
CUI: C1305855
Disease: Body mass index
Body mass index 		phenotype Clinical Attribute 1014 2689 0.100 None 1.000 5 1 2016 2019
CUI: C1333171
Disease: Primary Cutaneous Follicle Center Lymphoma
Primary Cutaneous Follicle Center Lymphoma 		disease Neoplastic Process 19 0.050 None 0.800 5 2002 2018
CUI: C0281710
Disease: Childhood Large Cell Lymphoma
Childhood Large Cell Lymphoma 		disease Neoplastic Process 30 0.040 None 1.000 4 1989 1994
CUI: C0334037
Disease: Intestinal metaplasia
Intestinal metaplasia 		phenotype Disease or Syndrome 266 24 0.040 None 0.500 4 1999 2017
CUI: C0521158
Disease: Recurrent tumor
Recurrent tumor 		phenotype Neoplastic Process 735 33 0.040 None 1.000 4 2000 2016
CUI: C0677932
Disease: Progressive Neoplastic Disease
Progressive Neoplastic Disease 		phenotype Neoplastic Process 384 40 0.040 None 1.000 4 2013 2019
CUI: C0854868
Disease: Non-Hodgkin's lymphoma transformed recurrent
Non-Hodgkin's lymphoma transformed recurrent 		disease Neoplastic Process 5 0.040 None 1.000 4 1992 2014
CUI: C0940937
Disease: precancerous lesions
precancerous lesions 		phenotype Neoplastic Process 270 19 0.040 None 1.000 4 1999 2017
CUI: C1333295
Disease: Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type
Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type 		disease Neoplastic Process 18 0.040 None 1.000 4 2004 2019
CUI: C1511566
Disease: cutaneous B-cell non-Hodgkin lymphoma
cutaneous B-cell non-Hodgkin lymphoma 		disease Neoplastic Process 16 0.040 None 1.000 4 2000 2007